Answers are grounded in this paper and cite their sources.
Vector borne diseases (VBDs) are a serious global health concern leading to more than 700,000 deaths annually. Worldwide, ticks are one of the deadliest vectors for both humans and animals. Due to the emergence of resistance to several acaricides, novel approaches are needed to aid in bringing tick populations and tick-borne pathogens (TBPs) under control. Our understanding and treatment of VBDs can be enhanced through focus on the biological response of the arthropod vector as an essential piece of the host-vector-pathogen tripartite system. Further, sugars are an essential component of host-pathogen interactions and play a role in arthropod immunity, blood feeding, pathogen transmission and can affect the human immune response, as evidenced by alpha-gal syndrome. Understanding the role of sugars could help us identify vulnerable points in tick and TBP transmission cycles for the development and implementation of novel drug therapeutics, antibody-based tools and highly-specific tick acaricides. This review highlights sugars and essential glycomolecules in tick immunity, feeding and pathogen transmission which are targeted in existing or potential sugar-related therapies. We then discuss possible advancements and limitations of these tools, emphasizing how tick glycobiology should be considered in the design and implementation of future tick and TBP control, surveillance and diagnostic strategies.
No takes yet. Share an insight, caveat, or question.
Wojtczak et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: